Trial
NCT02588950
A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
U-500R
Why stopped
Slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-23